Cleared Special

K161526 - LIAISON CMV IgM Serum Control Set

K161526 is an FDA 510(k) clearance for LIAISON CMV IgM Serum Control Set, manufactured by DiaSorin, Inc.. The device is a Class 1 Microbiology device with product code JJX cleared through the Special 510(k) pathway after a 28-day FDA review.

K161526 · DiaSorin, Inc. · Microbiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
28d
Days
Class 1
Risk

K161526 is an FDA 510(k) clearance for the LIAISON CMV IgM Serum Control Set. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on June 30, 2016 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 862.1660 - the FDA microbiology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K161526

510(k) Number K161526 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2016
Decision Date June 30, 2016
Days to Decision 28 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 102d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 481
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K161526.
Multichem A1c
K162514 · Technopath Manufacturing · Oct 2016
Audit MicroControls Linearity DROP LQ Blood Glucose
K161874 · Aalto Scientific, Ltd. · Aug 2016
LIAISON EBV IgM Serum Control Set
K161522 · DiaSorin, Inc. · Jun 2016
IDS-iSYS 17-OH Progesterone Control Set, IDS-iSYS 17-OH Progesterone Calibration Verifiers
K161082 · Immunodiagnostic Systems , Ltd. · May 2016
Dropper hsCRP High Sensitivity CRP Control
K152117 · Quantimetrix Corporation · Apr 2016
Contour Next Control Solution
K151742 · Bayer Healthcare · Sep 2015
K161526 · LIAISON CMV IgM Serum Control Set
Download PDF FDA Summary DiaSorin, Inc.